Skip to main content
. 2020 Jun 16;6(4):e61. doi: 10.1192/bjo.2020.44

Table 2.

Comparison of the diagnostic pathways for dementia with Lewy bodies (DLB) group versus non-DLB groupa

DLB group, mean (s.d.) range Non-DLB group, mean (s.d.) range Student's t-test P
Number of diagnoses before final diagnosis 0.8 (0.9) 0–4 0.4 (0.7) 0–3 3.08 0.002
Time between first secondary care appointment and final diagnosis (years) 1.2 (1.8) 0–8 0.6 (1.0) 0–5 2.42 0.017
Number of imaging tests before final diagnosis (including FP-CIT scan) 1.7 (1.0) 0–5 1.2 (0.8) 0–4 3.09 0.002
Number of clinical assessments at home before final diagnosis 3.9 (7.3) 0–40 1.8 (2.5) 0–15 2.31 0.02
Number of clinic appointments before final diagnosis 2.6 (5.7) 0–30 1.5 (2.2) 0–13 1.45 0.15

FP-CIT, 123I-N-ω-fluoropropyl-2beta-carbomethoxy-3beta-4-iodophenyl nortropane brain single-photon emission computerised tomography.

a.

How the DLB and non-DLB group reached their final diagnosis was compared, including the number of alternative diagnoses received before their final diagnosis.